Journals / İstanbul Tıp Dergisi / 2009 / Cilt: 10 - Sayı: 4

Konjonktival MALT lenfoma: Olgu sunumu

Conjunctival malt lymphoma: A case report

Pages
198–201
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this article, we are reporting 43 year old, female conjunctival MALT lymphoma demonstrative case with clinic and pathological specifications.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Whilst the etiology of the MALT (Mucosa Associate Lymphoid Tissue) lymphoma is not perfectly clarified, the blamed mechanism is a mature B-cell lymphoproliferative processes.
📊
Key Findings & Data:This process is considered to have developed in connection with chronic antigenic stimulation which belongs to the extranodal marginal zone B-cell nonhodgkin indolent lymphoma class.
💡
Conclusion & Impact:In this article, we are reporting 43 year old, female conjunctival MALT lymphoma demonstrative case with clinic and pathological specifications.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Whilst the etiology of the MALT (Mucosa Associate Lymphoid Tissue) lymphoma is not perfectly clarified, the blamed mechanism is a mature B-cell lymphoproliferative processes. This process is considered to have developed in connection with chronic antigenic stimulation which belongs to the extranodal marginal zone B-cell nonhodgkin indolent lymphoma class. A majority of the MALT lymphoma appear in the gastrointestinal system yet they may appear in tissue and organs like orbita, conjunctiva, lacrimal gland, bladder, lung, dura, thyroid, breast, and skin. Generally they have slow course and favorable prognoses. Chemotherapy and radiotherapy treatment options might be used. In this article, we are reporting 43 year old, female conjunctival MALT lymphoma demonstrative case with clinic and pathological specifications.

Özet

MALT (Mucosa associate lymphoid tissue) lenfoma, tam olarak sınıflandırılmamakla birlikte matür B hücrelerinin lenfoproliferatif mekanizması ile oluşur. Bu mekanizma kronik antijenik stimlasyon ile gelişir ve ekstranodal marjinal zon indolent B hücreli nonhodgkin lenfoma sınıfında yer alır. MALT lenfomaların çoğu gastrointestinal sistemde görüşülmekle birlikte orbita, konjunktiva, lakrimal gland, mesane, akciğer, dura, tiroid, meme, ve deri yerleşimli olabilir. Genellikle yavaş büyürler ve iyi prognozludurlar. Kemoterapi ve radyoterapi ile tedavi edilebilirler. Bu çalışmada, 43 yaşında, kadın konjunktiva yerleşimli MALT lenfoma tanısı alan ve tedavisi yapılan hasta klinik ve patolojik özellikleri ile tartışıldı.

🔖

Cite This Article

TUNA, S., DOĞAN, O., KARAÇETİN, D., BAŞARAN, M., AĞAOĞLU, F., BÜYÜKBABANI, N. (2022). Konjonktival MALT lenfoma: Olgu sunumu. İstanbul Tıp Dergisi, Cilt: 10 - Sayı: 4, 198–201. https://ajindex.com/articles/552643

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Parsonnet J, Hansen S, Rodriguez L et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med. 1994; 330: 1267-71
  2. Neubauer A, Thiede C, MorgnerAet al. Cure of Helicobacter pylori infection and duration of remission of lowgrade gastric mucosa-associated lymphoid tissue lymphoma. J Natl Cancer Inst. 1997; 89: 1350-5
  3. Ferreri AJ, Guidoboni M, Ponzoni M et al. Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas. J Natl Cancer Inst 2004; 96: 586-94
  4. Cerrani L, Zochling N, Putz B et al. Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma. J Cutan Pathol 1997; 24: 457-61
  5. Roggero E, Zucca E, Mainetti C et al. Eradication of Borrelia burgdorferi infection in primary marginal zone Bcell lymphoma of the skin. Hum Pathol 2000; 31: 263-8
  6. Luppi M, Longo G, Ferrari MG et al. Additional neoplasms and HCV infection in low-grade lymphoma of MALT type. Br J Haematol 1996; 94: 373-5
  7. Ascoli V, Lo Coco F, Artini M et al. Extranodal lymphomas associated with hepatitis C virus infection. Am J Clin Pathol 1998; 109: 600-9
  8. Minasian MC, Sharma A, Richman PI et al. Conjunctival MALT lymphoma: an unusual cause of red eye. Postgrad Med J 1999; 75: 423-4
  9. Tanimoto K, Kaneko A, Suziki S et al. Long-term follow- up results of no initial therapy for ocular adnexal MALT lymphoma. Annals of Oncology 2006; 17: 135-40
  10. Uno T, Isobe K, Shikama N et al. Radiotherapy for extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa: multiinstitutional, retrospective review of 50 patients. Cancer 2003; 98: 865-71
  11. Song K-E, Kim Y-S, Kim MT et al. Efficacy of chemotherapy as first line treatment in ocular adnexal extranodal marginal zone B-cell lymphoma. Annals of Oncology Advance Access published october 17, 2007. Annals of Oncology doi:10.1093/annonc/mdm457
  12. Ferreri AJ, Ponzoni M, Martinelli G et al. Rituximab in patients with mucosal-associated lymphoid tissue-type lymphoma of the ocular adnexa. Haematologica 2005; 90: 1578-9
  13. Ferrei AJ, Panzoni M, Guidoboni M et al. Regression of ocular adnexal lymphoma after Chlamydia psittaci-eradicating antibiotic therapy. J Clin Oncol 2005; 23: 5067-73
  14. Blasi MA, Gherlinzoni F, Calvisi G et al. Local chemotherapy with interferon-alpha for conjunctival mucosa-associated lymphoid tissue lymphoma: a preliminary report. Ophthalmology 2001; 108: 559-62
  15. Matsuo T, Yoshino T. Long-term follow-up results